Ferozsons Laboratories Limited (PSX:FEROZ)
Pakistan · Delayed Price · Currency is PKR 400.91
+12.80 (3.30%)
At close: May 8, 2026
Ferozsons Laboratories Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 22,677 | 18,857 | 15,855 | 11,457 | 9,330 | 8,879 | |
Revenue Growth (YoY) | 24.85% | 18.93% | 38.38% | 22.80% | 5.08% | 42.93% |
Cost of Revenue | 12,558 | 10,895 | 9,418 | 7,252 | 5,380 | 5,246 |
Gross Profit | 10,120 | 7,962 | 6,436 | 4,206 | 3,950 | 3,633 |
Selling, General & Admin | 7,519 | 5,819 | 4,605 | 3,183 | 2,641 | 2,085 |
Other Operating Expenses | 344.79 | 206.99 | 241.41 | 51.41 | 79.7 | 108.11 |
Operating Expenses | 7,864 | 6,026 | 4,848 | 3,256 | 2,731 | 2,193 |
Operating Income | 2,256 | 1,935 | 1,589 | 949.17 | 1,219 | 1,440 |
Interest Expense | -371.91 | -550.69 | -648.39 | -295.51 | -83.29 | -31.44 |
Interest & Investment Income | 150.67 | 150.67 | 56.02 | 206.68 | 232.06 | 81.89 |
Currency Exchange Gain (Loss) | -48.08 | -48.08 | 33.35 | -478.9 | -161.84 | 47.23 |
Other Non Operating Income (Expenses) | -23.59 | -23.59 | -24.06 | -8.6 | -12.99 | -12.26 |
EBT Excluding Unusual Items | 1,963 | 1,464 | 1,006 | 372.84 | 1,193 | 1,525 |
Gain (Loss) on Sale of Investments | 67.85 | 67.85 | 56.11 | 12.99 | 8.69 | 2.45 |
Gain (Loss) on Sale of Assets | 24.03 | 24.03 | 78.51 | 28.84 | 35.11 | 38.17 |
Pretax Income | 2,055 | 1,555 | 1,140 | 414.67 | 1,237 | 1,566 |
Income Tax Expense | 879.49 | 633.75 | 384.74 | 118.43 | 447.13 | 277.51 |
Earnings From Continuing Operations | 1,175 | 921.71 | 755.48 | 296.24 | 789.79 | 1,288 |
Minority Interest in Earnings | -233.34 | -145.17 | -72.33 | -24.97 | -55.36 | -115.01 |
Net Income | 941.68 | 776.54 | 683.15 | 271.27 | 734.43 | 1,173 |
Net Income to Common | 941.68 | 776.54 | 683.15 | 271.27 | 734.43 | 1,173 |
Net Income Growth | 24.95% | 13.67% | 151.84% | -63.06% | -37.41% | 181.42% |
Shares Outstanding (Basic) | 43 | 43 | 43 | 43 | 43 | 43 |
Shares Outstanding (Diluted) | 43 | 43 | 43 | 43 | 43 | 43 |
Shares Change (YoY) | -0.02% | - | - | - | - | - |
EPS (Basic) | 21.66 | 17.86 | 15.72 | 6.24 | 16.90 | 27.00 |
EPS (Diluted) | 21.66 | 17.86 | 15.72 | 6.24 | 16.90 | 27.00 |
EPS Growth | 24.97% | 13.67% | 151.84% | -63.06% | -37.41% | 181.42% |
Free Cash Flow | -544.15 | 771.95 | -1,079 | -2,861 | -1,457 | 609.77 |
Free Cash Flow Per Share | -12.52 | 17.76 | -24.83 | -65.82 | -33.52 | 14.03 |
Dividend Per Share | - | 4.000 | 3.000 | - | 4.167 | 8.333 |
Dividend Growth | - | 33.33% | - | - | -50.00% | 200.00% |
Gross Margin | 44.63% | 42.22% | 40.60% | 36.71% | 42.34% | 40.92% |
Operating Margin | 9.95% | 10.26% | 10.02% | 8.28% | 13.07% | 16.22% |
Profit Margin | 4.15% | 4.12% | 4.31% | 2.37% | 7.87% | 13.22% |
Free Cash Flow Margin | -2.40% | 4.09% | -6.81% | -24.97% | -15.62% | 6.87% |
EBITDA | 3,272 | 2,851 | 2,106 | 1,421 | 1,640 | 1,838 |
EBITDA Margin | 14.43% | 15.12% | 13.28% | 12.40% | 17.58% | 20.70% |
D&A For EBITDA | 1,017 | 915.61 | 517.09 | 471.85 | 420.85 | 397.99 |
EBIT | 2,256 | 1,935 | 1,589 | 949.17 | 1,219 | 1,440 |
EBIT Margin | 9.95% | 10.26% | 10.02% | 8.28% | 13.07% | 16.22% |
Effective Tax Rate | 42.81% | 40.74% | 33.74% | 28.56% | 36.15% | 17.72% |
Advertising Expenses | - | 762.88 | 712.1 | 385.33 | 301.07 | 286.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.